✦ LIBER ✦

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma : A report from the Children's Oncology Group

✍ Scribed by Alexander J. Chou; Eugenie S. Kleinerman; Mark D. Krailo; Zhengjia Chen; Donna L. Betcher; John H. Healey; Ernest U. Conrad III; Michael L. Nieder; Michael A. Weiner; Robert J. Wells; Richard B. Womer; Paul A. Meyers; on behalf of the Children's Oncology Group

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 371 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24566

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AAML03P1, a pilot study of the safety of

AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia : A report from the Children's Oncology Group

✍ Todd M. Cooper; Janet Franklin; Robert B. Gerbing; Todd A. Alonzo; Craig Hurwitz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB 👁 2 views

Regimen-related toxicity of myeloablativ

✍ Grovas, Alfred C.; Boyett, James M.; Lindsley, Karen; Rosenblum, Marc; Yates, Al 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

Background. The survival of children with glioblastoma multiforme (GBM) remains poor. In an effort to improve the cure rate of children with this disease, high-dose chemotherapy followed by autologous stem cell rescue (ASCR) has been evaluated. We report the regimenrelated toxicity (RRT) and surviva